Sign In
Buy IMMP
$0.407
-0.0093 (-2.24%)
At Close: Jun 03, 2026
Immutep Announces Chinese Patent Grant for LAG-3 Antagonist Antibody LAG525
08:00am, Friday, 27'th Aug 2021
Sydney, Aug. 27, 2021 (GLOBE NEWSWIRE) -- SYDNEY, AUSTRALIA – 27 August 2021 – Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), is pleased to announce the grant of pate
Immutep Reports Dosing of First Patient for Triple Combination (efti + anti-PD-1 + chemo) in INSIGHT-003
08:00am, Thursday, 05'th Aug 2021
Sydney, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments
Immutep Shares Are Trading Higher On Green Signal To Start Efti Combo Trial In First-Line Head & Neck Cancer
07:20am, Tuesday, 06'th Jul 2021
Immutep Limited (NASDAQ: IMMP) has completed all the necessary steps with the FDA and has received institutional review board approval to commence its Phase 2b TACTI-003 trials in the U.S. Patient
7 Reddit Penny Stocks to Buy if You Have $100 to Spare
02:35pm, Wednesday, 09'th Jun 2021
Reddit penny stocks are full of risk and reward, which is why $100 won't hurt you, but it can reward you handsomely. The post 7 Reddit Penny Stocks to Buy if You Have $100 to Spare appeared first on I
Immutep Reports Positive Data from its TACTI-002 Phase II Study of LAG-3 Therapy, Efti, at ASCO 2021
08:00am, Friday, 04'th Jun 2021
SYDNEY, AUSTRALIA, June 04, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy
Immutep, Merck Germany Team Up for Eftilagimod/Bintrafusp Combo Trial In Solid Tumors
09:05am, Tuesday, 01'st Jun 2021
Immutep Limited (NASDAQ: IMMP) has announced a new collaboration and supply agreement with Germany-based Merck KGaA (OTC: MKGAF) for a Phase 1/2a INSIGHT-005 trial in patients with solid tumors.
IMMP Stock Price: Over 14% Increase Pre-Market Explanation
05:53am, Wednesday, 26'th May 2021
The stock price of Immutep Limited (NASDAQ: IMMP) increased by over 14% pre-market. This is why it happened.
Immutep To Present At The Jefferies Virtual Healthcare Conference
08:00am, Tuesday, 25'th May 2021
SYDNEY, AUSTRALIA, May 25, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for c
Immutep Stock Gains on Encouraging Data from Early-Stage Solid Cancer Studies
11:20am, Thursday, 20'th May 2021
Immutep Limited (NASDAQ: IMMP) has announced that data from its TACTI-002 and INSIGHT-004 studies have been published in abstracts for the American Society of Clinical Oncology's 2021 Annual Meeti
Top Penny Stocks to Buy Now? 4 Big Movers to Watch Today
09:00am, Thursday, 20'th May 2021
Are these the top penny stocks to buy in 2021? Take a look and decide for yourself The post Top Penny Stocks to Buy Now?
7 Reddit Penny Stocks Promising to Cure Cancer
10:25am, Friday, 14'th May 2021
These seven risky Reddit penny stocks are in the biotech space and the business of developing cancer therapies and treatments. The post 7 Reddit Penny Stocks Promising to Cure Cancer appeared first on
Immutep To Announce New TACTI-002 and INSIGHT-004 Data in Poster Presentations and Discussion at the ASCO 2021 Annual Meeting
10:21am, Wednesday, 28'th Apr 2021
SYDNEY, Australia, April 28, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), the leading developer of LAG-3 related immunotherapy treatments for c
Immutep Receives A$1,155,055 R&D Tax Incentive
08:00am, Friday, 16'th Apr 2021
SYDNEY, AUSTRALIA, April 16, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased to announce that it has received a A$1,155,055 cash re
Why Immutep Limited Stock Popped Today
05:17pm, Thursday, 08'th Apr 2021
Investors liked the company's latest regulatory update.
Sydney, AUSTRALIA, April 08, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments f
